In This Section      
Print This Page

Current News Releases

Current News Releases

Released: September 25, 2017


Below are brief descriptions of research results scheduled for presentation by Johns Hopkins Kimmel Cancer Center scientists at the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24–27, in San Diego.

Released: September 25, 2017

Johns Hopkins researchers develop an electronic triage tool to more accurately differentiate patients’ priority levels


When a patient arrives in any emergency department, one of the first steps in their care process is triage, an opportunity for a care team member to identify critically ill patients and assign priority treatment levels.

Released: September 21, 2017


With the number of opioid-related overdose deaths reaching epidemic proportions in the United States, providers and staff at hospitals and health systems are joining together to combat the issue while preventing new cases of addiction.

Released: September 20, 2017


Ellen Mowry, M.D., M.C.R., an associate professor of neurology and epidemiology, and Scott Newsome, D.O., an associate professor of neurology, both of the Johns Hopkins University Department of Neurology, have been approved for a $13.4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to conduct a study comparing two treatment options for people newly diagnosed with the relapsing-remitting form of multiple sclerosis (MS).
Released: September 20, 2017

Gunshot and Stabbing Victims More Likely to Die if Transported to the Trauma Center by Ambulance


Victims of gunshots and stabbings are significantly less likely to die if they’re taken to the trauma center by a private vehicle than ground emergency medical services (EMS), according to results of a new analysis.

Released: September 20, 2017


In an analysis of the epigenomes of people and mice, researchers at Johns Hopkins Medicine and the National Institutes of Health report that drinking alcohol may induce changes to a cholesterol-regulating gene.

Released: September 19, 2017


The Johns Hopkins Hospital will join the ranks of more than 200 organizations that have been accredited as CEO Cancer Gold Standard employers by meeting standards of excellence in cancer prevention, early detection and quality care for their employees. The accreditation is given by the CEO Roundtable on Cancer, a nonprofit group of CEOs founded by former President George H.W. Bush
Released: September 18, 2017

Study shows the behavior responds to lithium treatment, just as used in people with the disorder


Johns Hopkins researchers report they have genetically engineered mice that display many of the behavioral hallmarks of human bipolar disorder, and that the abnormal behaviors the rodents show can be reversed using well-established drug treatments for bipolar disorder, such as lithium.

Released: September 14, 2017


A “look back” analysis of more than 600 major colorectal surgeries using a “checklist” tool has added further evidence that racial and socioeconomic disparities may occur during many specific stages of surgical care, particularly in pain management.

Released: September 13, 2017

Novel way to present pancreatic proteins increases the sensitivity of Type 1 Diabetes Tests


Researchers from the Johns Hopkins University School of Medicine, Stanford University and the University of Florida report the development of a novel antibody detection technology that holds promise for improving the accuracy of diagnostic tests for type 1 diabetes in young children and making population wide screening practical.
Released: September 12, 2017

Medical samples transported 160+ miles by unmanned aircraft in Arizona desert


Johns Hopkins researchers have set a new delivery distance record for medical drones, successfully transporting human blood samples across 161 miles of Arizona desert. Throughout the three-hour flight, they report, the on-board payload system maintained temperature control, ensuring the samples were viable for laboratory analysis after landing.

Released: September 11, 2017


Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called “epigenetic” changes in the cells consistent with the earliest steps toward lung cancer development.

Released: September 7, 2017

Multi-hospital effort across Johns Hopkins system improves care and saves money, investigators say


A five-year effort across the Johns Hopkins Health System to reduce unnecessary blood transfusions and improve patient care has also resulted in an annual cost savings of more than $2 million, researchers report.

Released: September 6, 2017

Patient demand and profit motives also factor in


A new national survey of more than 2,000 physicians across multiple specialties finds that physicians believe overtreatment is common and mostly perpetuated by fear of malpractice, as well as patient demand and some profit motives.

Released: September 6, 2017

M-1 Ventures’ accelerator program to provide emerging businesses funding and mentorship from experts at Johns Hopkins, Plank Industries and the University of Maryland


Today, M-1 Ventures announced the six startups selected to participate in an intense 16-week program in Baltimore designed to set emerging businesses in the connected health and fitness industry on a fast track to success. This accelerator program operates with the support of Johns Hopkins Technology Ventures, Plank Industries, the University of Maryland (through UM Ventures), Brown Advisory and the Abell Foundation.

Released: September 4, 2017


Johns Hopkins scientists say they have developed a blood test that spots tumor-specific DNA and protein biomarkers for early-stage pancreatic cancer. The combined “liquid biopsy” identified the markers in the blood of 221 patients with the early-stage disease.
Released: August 31, 2017


Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study’s findings, published in the August issue of The Journal of Clinical Endocrinology & Metabolism, adds further support for the consistent use of continuous positive airway pressure (CPAP), a machine that increases air pressure in the throat to keep the airway open during sleep. 

Released: August 31, 2017

Researchers find new sleep-promoting cells


Johns Hopkins researchers report the unexpected presence of a type of neuron in the brains of mice that appears to play a central role in promoting sleep by turning ‘off’ wake-promoting neurons. The newly identified brain cells, located in a part of the hypothalamus called the zona incerta, they say, could offer novel drug targets to treat sleep disorders, such as insomnia and narcolepsy, caused by the dysfunction of sleep-regulating neurons.

Released: August 30, 2017


In a mouse study designed to understand how chronic inflammation in sinusitis damages the sense of smell, scientists at Johns Hopkins say they were surprised to learn that the regeneration of olfactory tissue requires some of the same inflammatory processes and chemicals that create injury and loss of smell in the first place.

Released: August 28, 2017


In a randomized, double-blind, clinical trial of 212 patients, Johns Hopkins researchers have found that the routine use of fentanyl for sedation and comfort during coronary angiography reduces the effectiveness of the platelet blocking drug ticagrelor, and it doesn’t appear to provide any better pain relief than just local anesthesia.